HOME >> BIOLOGY >> NEWS
Alejandro Zaffaroni to receive 2006 Biotechnology Heritage Award

The Chemical Heritage Foundation (CHF) and the Biotechnology Industry Organization (BIO) will present the 8th Annual Biotechnology Heritage Award to Alejandro Zaffaroni, an outstanding pioneer of the biotechnology revolution and legendary entrepreneur with considerable scientific and business skills. The award will be presented at the plenary breakfast session from 7:30 to 9:00 a.m. on Monday, 10 April, at BIO 2006 at McCormick Place Convention Center in Chicago.

"Dr. Zaffaroni's scientific contributions, particularly in the area of drug delivery, have enhanced health care for people throughout the world," stated BIO president Jim Greenwood. "His steadfast commitment to research and development has earned him more than two dozen patents and the deep-founded respect of his colleagues."

"Alex Zaffaroni helped to guide Syntex to success in the 1950's, and has gone on to give the world a half-century of life-saving innovations through his commitment to novel drug delivery and his inspired entrepreneurship," said Arnold Thackray, president of CHF. "He embodies the spirit that is making biotechnology a living, thriving reality."

Alejandro Zaffaroni
Over a long and distinguished career, Zaffaroni has founded and cofounded many companies that have become world leaders in medical technology. A native of Montevideo, Uruguay, Zaffaroni joined Syntex Corporation in 1951. At the time, Syntex was a small chemical company in Mexico that was becoming prominent in steroid research. He subsequently played a key role in transforming Syntex into a major pharmaceutical company that pioneered the development of the birth control pill.

Zaffaroni developed controlled drug delivery technology, more commonly known as "the patch," and founded ALZA Corporation to bring this important technology to the world market. In addition to ALZA, Zaffaroni founded DNAX, Affymax, Affymetrix, Maxygen, SurroMed, and Alexza--all companies that developed and mar
'"/>

Contact: Neil Gussman
neilg@chemheritage.org
215-873-8262
Chemical Heritage Foundation
24-Apr-2006


Page: 1 2

Related biology news :

1. Carnegie Mellons Peter Adams receives EPA research grant
2. 2007 EURYI: 20 young researchers to receive Nobel Prize-sized awards for breakthrough ideas
3. Fedoroff, of Penn State, to receive National Medal of Science
4. Philadelphia ecologist receives top Mongolia honor
5. Nearly 90 percent of babies receive recommended newborn screening tests
6. VIB scientist receives major research grant
7. Maynard Olson receives $500,000 Gruber Genetics Prize
8. University of Cincinnati receives $1.7M to research molecular treatment of brain injury
9. UGA scientists receive $20M in federal bioenergy initiative
10. Wright State scientist receives grant to help clean up polluted American harbors
11. UCR biologist receives $1.75 million grant to study plant-threatening bacteria

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
(Date:3/31/2016)... 2016   LegacyXChange, ... "Company") LegacyXChange is excited to release its ... to be launched online site for trading 100% guaranteed ... will also provide potential shareholders a sense of the ... an industry that is notorious for fraud. The video ...
Breaking Biology News(10 mins):
(Date:4/27/2016)... ... April 27, 2016 , ... The Board ... the appointment of John Tilton as Chief Commercial Officer.  Mr. Tilton joined Biohaven ... the founding commercial leaders responsible for the commercialization of multiple orphan drug indications. ...
(Date:4/27/2016)... ... April 27, 2016 , ... A compact ... Emission Tomography) and MRI (Magnetic Resonance Imaging) in existing third-party MRI systems. PET ... treatments in small animal subjects. Simultaneous PET/MRI imaging offers a solution to many ...
(Date:4/27/2016)... 27, 2016 MedDay, a biotechnology company ... the appointment of Catherine Moukheibir as Chairman of its Board ... Jean Jacques Garaud , who contributed to the rapid ... immediately. Catherine started her career in strategy consulting ... London .  She held C-Suite level roles ...
(Date:4/26/2016)... ... April 26, 2016 , ... ... Ardy Arianpour has joined the company as Chief Business Officer. Arianpour, a genomics ... genomic technologies to market, was most recently Chief Commercial Officer of Pathway Genomics. ...
Breaking Biology Technology:
Cached News: